BioMarin Pharmaceutical Inc. buy Robert W. Baird
Start price
13.07.23
/
50%
€76.16
Target price
13.07.24
€113.58
Performance (%)
-9.61%
Price
30.05.24
€68.80
Summary
This prediction is currently active. With a performance of -9.61%, the BUY prediction by Robert_W__Baird is trending in the wrong direction. This prediction currently runs until 13.07.24. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.178% | -1.178% |
| iShares Core DAX® | -0.552% | 3.405% |
| iShares Nasdaq 100 | -1.415% | 4.613% |
| iShares Nikkei 225® | -0.877% | -1.396% |
| iShares S&P 500 | -0.415% | 3.338% |
Comments by Robert_W__Baird for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $127.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Robert_W__Baird for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.64
30.01.24
30.01.24
€95.95
30.01.25
30.01.25
-16.75%
30.05.24
30.05.24
